Correction: Ono, S.; Lam, S.; Nagahara, M.; Hoon, D.S.B. Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays. J. Clin. Med. 2015, 4, 1890–1907

By Ono Shigeshi   Lam Stella   Nagahara Makoto   Hoon Dave S. B.  

Journal of Clinical Medicine, Vol. 5, Iss. 9, 2016-09 ,pp. : 81-81

MDPI

Access to resources Recommend Favorite

MicroRNA Signatures as Biomarkers and Therapeutic Target for CNS Embryonal Tumors: The Pros and the Cons

By Shalaby Tarek   Fiaschetti Giulio   Baumgartner Martin   Grotzer Michael A.  

International Journal of Molecular Sciences, Vol. 15, Iss. 11, 2014-11 ,pp. : 21554-21586

MDPI

Access to resources Recommend Favorite

Circulating microRNAs as Prognostic and Predictive Biomarkers in Patients with Colorectal Cancer

By Schou Jakob Vasehus   Johansen Julia Sidenius   Nielsen Dorte   Rossi Simona  

Non-Coding RNA, Vol. 2, Iss. 2, 2016-06 ,pp. : 5-5

MDPI

Access to resources Recommend Favorite

A Circulating MicroRNA Signature as a Biomarker for Prostate Cancer in a High Risk Group

By Kelly Brian D.   Miller Nicola   Sweeney Karl J.   Durkan Garrett C.   Rogers Eamon   Walsh Killian   Kerin Michael J.  

Journal of Clinical Medicine, Vol. 4, Iss. 7, 2015-07 ,pp. : 1369-1379

MDPI

Access to resources Recommend Favorite

MicroRNA In Lung Cancer: Novel Biomarkers and Potential Tools for Treatment

By Inamura Kentaro   Ishikawa Yuichi  

Journal of Clinical Medicine, Vol. 5, Iss. 3, 2016-03 ,pp. : 36-36

MDPI

Access to resources Recommend Favorite